We also showed that piritramide opioid analgesia reduces the presence of CTCs in colon cancer patients after surgery, potentially affecting survival [13,14], and that the expression of the cannabinoid-2 receptor (CB2) in cancer tissues improves survival in small-cell lung cancer [15]. This evidence concerns the gene CNR2 and malignant colon neoplasm.